The Ministry of Health is proceeding with plans to sell Intravacc, the state immunization agency that develops the vaccine. The production division he was sold to an Indian company in 2012, but the R&D division remains under government control.
Companies wishing to acquire Intravacc must bid through EY Strategy and Transactions by June 2nd. EY Strategy and Transactions is the state’s financial advisor on the sale. Institute website.
The sale was first discussed by then-Health Minister Edith Schippers in 2015, with preparations suspended during the coronavirus pandemic. However, the new Health Minister Ernst Kuipers has decided to continue the process.
He says having a Dutch vaccine laboratory adds little value and wants an EU-wide institution to ensure that the bloc is self-sufficient when it comes to vaccine development.
In February the NOS reported that MPs were concerned about the Dutch government’s decision to give its expertise in vaccine development to commercial companies. claimed that it would not fall into the hands of
The National Audit Office has also warned that it may not be in the interests of the Netherlands.
https://www.dutchnews.nl/news/2023/05/dutch-state-to-press-ahead-with-sale-of-vaccine-institute-intravacc/ Dutch government pushes sale of vaccine lab Intravacc